Cel Sci CVM
NYSE CVM
$1.51 -0.03 (-2.25%)
As of: Oct 21, 2026 · 11:37 AM EDT

Cel Sci (CVM) Long-Term Deferred Tax (2021 - 2023)

Updated

Cel Sci's Long-Term Deferred Tax came in at $60 million for fiscal Q4 2023 (quarter ended Sep 30, 2023), up 13.4% from $52.9 million a year earlier.

Analysis

Cel Sci (CVM) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends

  • Going back by fiscal year, Long-Term Deferred Tax was $52.9 million in FY2022 (+20.0%) and $44.1 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.87 Bn 1,099.45 Bn 19.71 Bn
2 Johnson & Johnson 614.49 Bn 533.02 Bn 17.26 Bn
3 AbbVie 502.45 Bn 475.56 Bn 12.70 Bn
4 Merck 368.35 Bn 322.73 Bn 12.21 Bn
5 Novartis Ag 298.42 Bn 262.41 Bn 11.24 Bn
6 Astrazeneca 261.95 Bn 235.64 Bn 12.86 Bn
7 Amgen 235.96 Bn 191.36 Bn 7.24 Bn
8 Gilead Sciences 191.17 Bn 165.37 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Cel Sci 2.72 Mn -22.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 60.00 Mn
Sep 30, 2022 52.90 Mn
Sep 30, 2021 44.10 Mn
API Access

Cel Sci Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=CVM&period=max&api_key=YOUR_API_KEY